Figure 1.
Gata2 germline variation blocks HSPC expansion after acute G-CSF treatment. (A) Configuration of Gata2 variant alleles in WT and CH. (B) Mice were treated with 1 dose of 125 mg/kg rhG-CSF or vehicle and harvested after 4 or 16 hours. (C) Representative flow cytometric plots for BM HSPC quantification. The numbers represent the percentage of the parent cell population. N = 6 to 9 per condition, 4 experiments (D) BM HSPC quantification. HSC: Lin− Sca1+ Kit+ (LSK) CD48– CD150+; MPP: LSK CD48– CD150–; LSK CD48+; Lin– Sca1– c-Kit+. ∗P < .05, ∗∗P < .01, ∗∗∗P < .001; 1-way ANOVA followed by Tukey multiple comparisons test. FSC, forward scatter; PBS, phosphate-buffered saline.

Gata2 germline variation blocks HSPC expansion after acute G-CSF treatment. (A) Configuration of Gata2 variant alleles in WT and CH. (B) Mice were treated with 1 dose of 125 mg/kg rhG-CSF or vehicle and harvested after 4 or 16 hours. (C) Representative flow cytometric plots for BM HSPC quantification. The numbers represent the percentage of the parent cell population. N = 6 to 9 per condition, 4 experiments (D) BM HSPC quantification. HSC: Lin Sca1+ Kit+ (LSK) CD48 CD150+; MPP: LSK CD48 CD150; LSK CD48+; Lin Sca1 c-Kit+. ∗P < .05, ∗∗P < .01, ∗∗∗P < .001; 1-way ANOVA followed by Tukey multiple comparisons test. FSC, forward scatter; PBS, phosphate-buffered saline.

Close Modal

or Create an Account

Close Modal
Close Modal